IBRX — ImmunityBio, Inc.Today's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.

Congress trades
3
all time
Members · 12m
1
2 buys · 0 sells · by trade date
Latest filing
10-12
2026-10-12
Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
0
every row filed inside 45 days
13F holders
334
all listed · 2026-03-31
Congress: statutory ranges, filed up to 45 days after the trade · 13F: quarter-end snapshots, filed up to 45 days lateras of 2026-10-29

On Signals

ACTIVE HITS NAMING IBRX · NEWEST FILED FIRST · EVERY HIT CARRIES ITS RECEIPTSignals ↗
Active signal hits naming IBRX, newest filed first
KindWhoTraded → FiledSizeSrc
first disclosure of this ticker by this member within the corpus — era-scoped: coverage begins 2014-01-03, so an earlier first disclosure cannot be seen and is not claimed againstMcClainTraded → Filed +14d$1.0K–$15.0K

1–1 of 1 line · 1 hit · each kind word opens its exact rule · every hit is in signals.v1.json.

Congress 3Institutional 334

Congress · disclosure timeline

By trade date · 24 months · 2 rows ▲ buy, ▼ sell; height = lower bound (log scale); ringed = on Signals. Trade date, not filing date — the filing lag is in the table below.

2 dated disclosures in the window, placed by trade date; magnitudes are the disclosed lower bounds, against gridlines at $15K, $250K, $5M; 2 ringed marks are lines of the Signals row above, pinned in the table below.

Members active in IBRX

12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).
Members disclosing IBRX in the trailing 12 months
MemberRowsNet disclosed flow for this ticker: purchases minus sales, computed as a net range on the disclosed amounts. A lower bound is provable, never a point.Number of committees the member sat on as of their latest trade date in the window, from the cc0-legislators roster snapshot. Context, never an allegation; jurisdiction overlap needs the sector join.
Lisa C. McClain R–MI-92$2.0K to $30.0K2

1 member

Congressional disclosures

Signals rows first, then newestAll 3 rows ↗
Latest congressional filings mentioning IBRX, the rows on Signals first
FiledMemberSide · OwnerTraded · LagAmountRange · FlagsSrc
2026-10-12Lisa C. McClain R–MI-9 On SignalsBUY SP (spouse-owned)Traded 09-30 +12d$1K–$15K
2026-10-12Lisa C. McClain R–MI-9 On SignalsBUY SP (spouse-owned)Traded 09-28 +14d$1K–$15K
2023-04-17Daniel S. Goldman D–NY-10SELLTraded 03-06 +42d$1K–$15K

13F holders · Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt. · longs only

Top institutional holders of IBRX for quarter 2026-03-31, 1–25 of 334 holders
#FilerValueSecuritiesFlagsderived by Public Filings from this build's reviewed ticker-mapping holders list for this share class; that list carries each holder's share count, share change and filed date, which this table does not show, but no document links — the EDGAR link opens the filer's 13F list·§
1BlackRock, Inc.$202M1
derived ·§ EDGAR ↗
2STATE STREET CORP$136M1
derived ·§ EDGAR ↗
3VANGUARD PORTFOLIO MANAGEMENT LLC$125M1
derived ·§ EDGAR ↗
4VANGUARD CAPITAL MANAGEMENT LLC$116M1
derived ·§ EDGAR ↗
5D. E. Shaw & Co., Inc.$96.4M1
derived ·§ EDGAR ↗
6GEODE CAPITAL MANAGEMENT, LLC$61.6M1
derived ·§ EDGAR ↗
7TWO SIGMA INVESTMENTS, LP$33.6M1
derived ·§ EDGAR ↗
8MORGAN STANLEY$30.8M1
derived ·§ EDGAR ↗
9Woodline Partners LP$26.4M1
derived ·§ EDGAR ↗
10UBS Group AG$22.6M1
derived ·§ EDGAR ↗
11VOLORIDGE INVESTMENT MANAGEMENT, LLC$22.5M1
derived ·§ EDGAR ↗
12NORTHERN TRUST CORP$19.2M1
derived ·§ EDGAR ↗
13CHARLES SCHWAB INVESTMENT MANAGEMENT INC$19.0M1
derived ·§ EDGAR ↗
14BANK OF AMERICA CORP /DE/$18.8M1
derived ·§ EDGAR ↗
15SEB Asset Management AB$18.8M1
derived ·§ EDGAR ↗
16VANGUARD FIDUCIARY TRUST CO$16.3M1
derived ·§ EDGAR ↗
17BARCLAYS PLC$14.5M1
derived ·§ EDGAR ↗
18Private Advisor Group, LLC$12.6M1
derived ·§ EDGAR ↗
19ROYAL BANK OF CANADA$11.4M1
derived ·§ EDGAR ↗
20MILLENNIUM MANAGEMENT LLC$10.9M1
derived ·§ EDGAR ↗
21FEDERATED HERMES, INC.$10.6M1
derived ·§ EDGAR ↗
22SUSQUEHANNA INTERNATIONAL GROUP, LLP$9.0M1
derived ·§ EDGAR ↗
23Voleon Capital Management LP$8.9M1
derived ·§ EDGAR ↗
24Cetera Investment Advisers$7.3M1
derived ·§ EDGAR ↗
25Nuveen, LLC$6.7M1
derived ·§ EDGAR ↗
Show all 334 holders
Truncated by Public Filings. All 299 13F filers reporting this share class are listed. Method ↗

Crowding — not available in this build. No holder rows for the selected period, so no percentile can be ranked.

Congress ↔ notable managers · IBRX

Congress · last 90 days

Buyers
1 Lisa C. McClain R–MI-9 $2K–$30K
Sellers
0 — —

filed 2026-07-31 → 2026-10-29 · statutory ranges

Notable managers · quarter ended 2026-03-31

Adding
1 Gotham Asset Management $93.1K held
Trimming
0 — $0 held

by shares · $ = value heldNEW + ADD vs TRIM + EXIT, by share count. $ = reported value now, not the change. · IMMUNITYBIO INC

Merged timeline of congressional filings and notable-manager moves on IBRX
DateWhoChangeSize
2026-10-12Lisa C. McClain CongressBUY$1K–$15K
2026-10-12Lisa C. McClain CongressBUY$1K–$15K
2026-05-15Gotham Asset Management 13FNEW+12,137 sh

3 newest, by filing date · 13F rows are quarter-end snapshots, not trades

Congress vs filers

12 months
Congress net (rows)2 buy / 0 sell
Congress net ($ bound)$2.0K to $30.0K
Filersnot computedThe filer side needs per-issuer quarter-over-quarter actions, which the published aggregate does not carry for this issuer. Convergence and divergence are stated only when both sides are computed.